Colimust 1 MIU Injection
Marketer
Efedra Pharmaceuticals Pvt. Ltd.
Salt Composition
Colistimethate Sodium (1Million IU)
Overview Colimust 1 MIU Injection
Colimust 1 MIU Injection, an antibacterial medication, combats severe systemic bacterial infections. Primarily administered to critically ill hospitalized patients, it requires professional medical oversight. Self-injection is strictly prohibited. Dosage and treatment length are determined by your physician, tailored to infection severity and type. Consistent adherence to the prescribed regimen is crucial for optimal therapeutic outcomes. Potential adverse effects, including nausea, impaired speech, lightheadedness, vertigo, pyrexia, skin eruptions, and tingling sensations, are generally transient, resolving as the body adapts. Persistent or bothersome side effects necessitate immediate medical consultation. Prior to commencing treatment, disclose any antibiotic allergies, liver or kidney dysfunction. Pregnant or lactating individuals should seek medical guidance before use. Regular blood tests to monitor renal function and drug levels may be implemented by your doctor.
Uses of Colimust 1 MIU Injection
Life-threatening bacterial infestations
Major Benefits of Colimust 1 MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Colimust 1 MIU Injection:
- Slurred speech
- Upset stomach
- Dizziness
- Gastrointestinal disturbance
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Rash
- Fever
- Generalized itching
- Red spots or bumps
- Increased blood urea nitrogen
- Increased creatinine level in blood
- Decreased creatinine clearance
- Respiratory distress
- Apnea (absence of breathing)
- Renal toxicity
- Decreased urinary volume
How to use Colimust 1 MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Colimust 1 MIU Injection works:
Colimust 1 MIU injection is a bactericidal antibiotic, eliminating bacteria through disruption of their cellular membranes.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Colimust 1 MIU Injection and alcohol.
PregnancyCONSULT YOUR DOCTOR
The use of Colimust 1 MIU Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Colimust 1 MIU Injection safely. Studies in humans show minimal risk to the infant.
DrivingUNSAFE
Colimust 1 MIU Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, Colimust 1 MIU Injection requires careful administration. A modified dosage of Colimust 1 MIU Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Colimust 1 MIU Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Colimust 1 MIU Injection :
NA
Facts to Know About Colimust 1 MIU Injection
| Label | Value |
|---|---|
| Chemical Classification | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently